Illumina supports Canada's nationwide COVID-19 genome sequencing project

November 3, 2021

Data from 10,000 SARS-CoV-2 patients will be used to identify biomarkers that can help predict the potential risk of serious diseases and support the development of new therapies against COVID-19

San Diego, November 3, 2021/PRNewswire/-Illumina Inc.

Illumina Connected Analytics (ICA) is the company’s iconic bioinformatics solution, which will enable researchers to safely and confidentially move the pb-level data sets generated by CGEn, a national sequencing and informatics platform, from Toronto (The Center for Applied Genomics (TCAG) of SickKids Hospital (SickKids), Montreal (McGill Genome Center) and Vancouver (Michael Smith Genome Science Center, Canada) are the most advanced sequencers to a public “cloud” for economic development Used by researchers in some of the country’s leading research institutions and hospitals.

Alex Aravanis, MD, Chief Technology Officer and Head of Research and Product Development of Illumina, said: "We are proud to support and contribute to the ongoing work of the Canadian research community to better understand the role of human genetics in susceptibility to COVID-19

Dr.

Illumina sequencing technology is also used by another national project VirusSeq, which coordinates and funds expanded genome sequencing efforts and supports the sharing of data within an open and ethical framework

"VirusSeq enables our public health agency data to track transmission trends, discover new clusters and outbreaks and determine evolutionary virus characteristics that may affect public health and policy decisions in Canada," said Catalina Lopez-Correa, MD, PhD , Chief Scientific Officer and Executive Officer of CanCOGeN, Director of the Canadian Genome

Both HostSeq and VirusSeq are part of the Canadian COVID-19 Genome Network (CanCOGeN), a consortium led by the Canadian Genome, dedicated to generating accessible and usable genomic data, providing information for public health and policy decisions, and guiding treatment And vaccine development

ICA provides a comprehensive, private, cloud-based data platform that allows researchers to manage, analyze and explore larger volumes of multi-economic data in a secure, scalable and flexible environment

About Illumina

Illumina is improving human health by unleashing the power of the genome

Use of forward-looking statements

This press release contains forward-looking statements that involve risks and uncertainties, including the expected lower costs associated with the cost of storing and managing genomic data

Investor: Brian Blanchett 1 858.

Media: Dr.

View original content and download multimedia: https:// Illumina Corporation, Co.